EMA Considers EUA-Style Fast Track Decision For Molnupiravir

Article 5(3) Has Helped Speed Pandemic Response

 
• By Andrew McConaghie
EMA
The EMA's last use of a scientific opinion saw it green light GSK/Vir's antibody therapy faster than the US FDA. • Source: Getty Images

More from Europe

More from Geography